Our liposarcoma nomogram is a tool designed to predict the prognosis of a patient with liposarcoma, the most common soft tissue sarcoma, after the primary tumor has been removed by surgery. This tool predicts the likelihood of surviving five years and 12 years after surgery, based on the characteristics of the patient and the tumor, such as the specific liposarcoma histologic subtype.
Results produced by this tool are based on data from patients treated at MSK, a large research institution with surgeons who perform a high volume of liposarcoma procedures. All results must be understood in the context of each patient’s specific treatment plan. Patients and caregivers using this tool should discuss the result with the patient’s physician.
To gather the information required to use this nomogram, use our worksheet.